1-3 of 3
Volkmar Boehme
Close
Sort by
Journal Articles

A Prospective, Open-Label, Multicenter, Phase 2 Trial to Evaluate the Safety and Efficacy of the Combination of Tirabrutinib (ONO/GS-4059) and Entospletinib with and without Obinutuzumab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Nadine Kutsch, MD, Christian Pallasch, Eugen Tausch, Volkmar Boehme, Matthias Ritgen, Ruediger Liersch, Alexander Wacker, Georg Jacobs, Ralf Ulrich Trappe, Peter Dreger, Stephan Stilgenbauer, Danjie Zhang, Juliane M. Jürgensmeier, Pankaj Bhargava, Michael Hallek, Barbara F. Eichhorst, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4297.
https://doi.org/10.1182/blood-2019-130912
Published: 2019
Journal Articles

CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)

Clinical Trials & Observations
Volkmar Boehme, Norbert Schmitz, Samira Zeynalova, Markus Loeffler, Michael Pfreundschuh
Journal: Blood
Blood (2009) 113 (17): 3896–3902.
https://doi.org/10.1182/blood-2008-10-182253
Published: 2009
Journal Articles

CNS-Disease in Elderly Patients Treated with Modern Chemotherapy (CHOP-14) with or without Rituximab: An Analysis of CNS Events in the RICOVER-60 Trial of the German High-Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL).

Volkmar Boehme, MD, Samira Zeynalova, Eva Lengfelder, MD, Astrid Franke, MD, Marcel Reiser, MD, Hans Steinhauer, MD, Michael Clemens, MD, Christine Nickenig, MD, Maike de Witt, MD, Markus Loeffler, MD, Michael Pfreundschuh, MD, Norbert Schmitz, MD
Journal: Blood
Blood (2007) 110 (11): 519.
https://doi.org/10.1182/blood.V110.11.519.519
Published: 2007